Scholar Rock Holding (SRRK) Total Debt Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 58.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.02% |
| Dec 31, 2025 | 26.09% |
| Sep 30, 2025 | 25.35% |
| Jun 30, 2025 | -0.42% |
| Mar 31, 2025 | -0.30% |
| Dec 31, 2024 | 0.10% |
| Sep 30, 2024 | 26.20% |
| Jun 30, 2024 | 26.31% |
| Mar 31, 2024 | 26.47% |
| Dec 31, 2023 | 26.55% |
| Sep 30, 2023 | 1,926.85% |
| Jun 30, 2023 | 1,669.93% |
| Mar 31, 2023 | 1,426.81% |
| Dec 31, 2022 | 1,668.07% |
| Sep 30, 2022 | 1,472.74% |
| Jun 30, 2022 | 1,336.46% |
| Mar 31, 2022 | 457.31% |
| Dec 31, 2021 | 381.46% |
| Sep 30, 2021 | 250.69% |
| Jun 30, 2021 | 223.93% |
| Dec 31, 2020 | 187.46% |